Skip to main content

Table 1 Summary of studies investigating the presence of SARS-CoV-2 in semen samples

From: A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective

Study

Disease stage

No. of semen samples

Interval from diagnosis/ test sample

SARS CoV-2 (−) RT PCR samples

SARS CoV-2 (+) RT PCR samples

Song et al. [68]

Recovering man

12

1 Testesa

N/A

100% (13/13)

0

Guo et al. [62]

Recent/recovering

23

Median 32 days

100% (23/23)

0

Pan et al. [42]

Recovering

34

Median 31 days

100% (34/34)

0

Kayaaslan et al. [69]

Hospitalized patients in acute stage

16

Median 1 day

100% (16/16)

0

Holtman et al. [61]

Cohort study

16 recovered/2 acute phase of infection

18

8–54 days after absence of symptoms

100% (18/18)

0

Zhang et al. [70]

3 positive/7 recovering

10 expressed prostatic secretion

< 3 days after positive test, 1 day after SARS Cov-2 (−) test

100% 10/10

0

Li D et al. [71]

15 acute phase of infection + 23 recovered

38

Acute phase 6–11 days from symptoms onset,

2–3 days after clinical recovery

84% (32/38)

(13/15 + 19/23)

16% (6/38)

(4/15 + 2/23)

  1. a(from a deceased patient)